首页 | 本学科首页   官方微博 | 高级检索  
检索        

温阳利湿化瘀方对乙肝相关慢加急性肝衰竭患者早期血清内毒素和炎症因子的影响
引用本文:张修举,郭瑞,张引强,陈艳,宋烨闻.温阳利湿化瘀方对乙肝相关慢加急性肝衰竭患者早期血清内毒素和炎症因子的影响[J].中国中医急症,2022(1):38-41.
作者姓名:张修举  郭瑞  张引强  陈艳  宋烨闻
作者单位:中国中医科学院西苑医院
基金项目:国家自然科学基金面上项目(81673967)。
摘    要:目的 探讨温阳利湿化瘀方对乙肝相关慢加急性肝衰竭(HBV-ACLF)患者早期血清内毒素(ET)和炎症因子的影响.方法 将146例HBV-ACLF早期患者按照随机数字表法分为观察组与对照组各73例.对照组患者参照指南予以西医常规治疗,观察组在对照组治疗基础上采用温阳利湿化瘀方治疗.比较两组治疗前后的中性粒细胞/淋巴细胞比...

关 键 词:乙肝相关慢加急性肝衰竭  温阳利湿化瘀方  内毒素  炎症因子

Effect of Wenyang Lishi Huayu Decoction on Early Serum Endotoxin and Inflammatory Factors in Patients with HBV-related Chronic and Acute Liver Failure
Zhang Xiuju,Guo Rui,Zhang Yinqiang,Chen Yan,Song Yewen.Effect of Wenyang Lishi Huayu Decoction on Early Serum Endotoxin and Inflammatory Factors in Patients with HBV-related Chronic and Acute Liver Failure[J].Journal of Emergency in Traditional Chinese Medicine,2022(1):38-41.
Authors:Zhang Xiuju  Guo Rui  Zhang Yinqiang  Chen Yan  Song Yewen
Institution:(Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 110091,China)
Abstract:Objective:To investigate the effect of Wenyang Lishi Huayu Decoction on serum endotoxin(ET)and inflammatory factors in patients with hepatitis B-related acute-on-chronic liver failure(HBV-ACLF).Methods:A total of 146 patients with early HBV-ACLF were randomly divided into the observation group and control group,73 cases in each group.Patients in the control group were treated with routine western medicine according to the guidelines,while patients in the observation group were treated with Wenyang Lishi Huayu Decoction on the basis of the control group.The neutrophil/lymphocyte ratio(NLR),serum interleukin-6(IL-6)and ET levels before and after treatment were compared between the two groups.The differences of liver function indexes,TCM syndrome score,MELD score and coagulation function between the two groups were observed,and the curative effect of TCM syndrome was compared between the two groups.Results:The levels of NLR,IL-6 and ET in the observation group after treatment were significantly lower than those in the control group(P<0.05).After treatment,the liver function index and coagulation function index in the observation group were significantly improved compared with those in the control group(P<0.05).The TCM syndrome score and MELD score of the observation group at 1 week,2 weeks and 3 weeks after treatment were significantly lower than those of the control group(P<0.05).The total effective rate of TCM syndrome in the observation group was 86.30%,which was significantly higher than65.75%in the control group(P<0.05).Conclusion:On the basis of Western medicine treatment,Wenyang Lishi Huayu Decoction in the treatment of HBV-ACLF patients can significantly improve their liver function and coagulation function indexes,and the curative effect is good,which is helpful for the severity of the disease and the TCM syndrome score,and its mechanism may be related to the reduction of serum endotoxin and inflammatory factors.
Keywords:HBV-related chronic and acute liver failure  Wenyang Lishi Huayu Decoction  Endotoxin  Inflammatory factors
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号